您好,游客 登录 注册 站内搜索
背景:
阅读论文

我们提供专业的医学SCI论文翻译润色服务

来源:医学期刊论文发表  作者:医学期刊论文发表 [字体: ]

     针对已有英文初稿的论文,我们会选择相应学科资深专家对论文结构、科学逻辑、实验设计、所得结论,以及对标点、纠正单词用法、拼写和语法错误、字体和字体大小的一致性、含糊的陈述和结构不好的句子、动词和主语的一致等方面作进一步修饰,从而增加论文发表的机会。

润色案例

 

SCI论文翻译:针对已有中文初稿的论文,我们会选择相应学科资深专家,根据SCI杂志的写作要求在忠实于原文的情况下调整您的中文学术论文结构,对可能出现的问题提供专业的修改意见。先由高级英文编辑将客户的中文学术论文准确、专业地翻译 成英文论文,再经过英语为母语的外籍英文编辑对其进行母语化润色,使英文论文的表达方式达到SCI论文投稿的要求。

翻译案例

原文

肿瘤组织和外周血中RRM1、ERCC1表达水平与晚期非小细胞肺癌吉西他滨/卡铂化疗相关性

摘要 
目的:探讨晚期非小细胞肺癌(NSCLC)肿瘤组织和外周血淋巴细胞中RRM1、ERCC1基因表达水平及其临床意义。 
方法:应用实时荧光定量PCR技术检测49例晚期NSCLC肿瘤组织和外周血淋巴细胞中RRM1、ERCC1 mRNA表达水平,对照分析其与患者临床特征、吉西他滨/卡铂方案的化疗反应以及预后的关系。 
结果:肿瘤组织和外周血淋巴细胞中RRM1表达水平呈正相关(rs=0.332,P<0.05),而ERCC1无相关(rs=0.258,P>0.05);肿瘤组织或外周血淋巴细胞中RRM1和ERCC1表达几乎同步(rs=0.634、0.351,P<0.05),但基因表达与患者的性别、年龄、吸烟状态、体力状况PS评分,以及肿瘤临床分期和组织学类型均无显著相关性(P均>0.05)。肿瘤组织中RRM1、ERCC1或外周血RRM1低表达者化疗有效率、中位生存期及1年生存率均高于高表达者,两者比较差异均有统计学意义(P<0.05),特别是肿瘤组织ERCC1低表达者有较高的2年生存率(P<0.05);而外周血ERCC1表达水平与化疗疗效以及预后均无相关性(P均>0.05)。 
结论:肿瘤组织中RRM1、 ERCC1和外周血淋巴细胞中RRM1基因表达水平可能与晚期NSCLC患者吉西他滨/卡铂化疗的疗效以及预后密切相关。

翻译完的文章:

Expression of RRM1 and ERCC1 genes in tumor tissues and peripheral blood lymphocytes of advanced non-small cell lung cancer

Abstract: 
Objective: To investigate the expression of RRM1 and ERCC1 genes in tumor tissues and peripheral blood lymphocytes of advanced non-small cell lung cancer (NSCLC). 
Methods: Tissue and peripheral blood samples were collected from 49 advanced NSCLC patients treated with gemcitabine plus carboplatin.The expressions of RRM1 and ERCC1 mRNA in tumor tissue and peripheral lymphocytes were detected by real-time fluorescent quantitative PCR.The relationship of gene expression with clinical characteristics,chemotherapy response and prognosis was analyzed. 
Results: The RRM1 expression in tumor tissues was positively correlated with that in peripheral blood lymphocytes,while no significant correlation was observed between ERCC1 expression in tumor tissues and that in peripheral blood (rs=0.332 and 0.258;P=0.020 and 0.073,respectively).The expression of RRM1 and ERCC1 in tumor tissues peripheral lymphocytes was synchronous(rs=0.634 and 0.351;P<0.001 and 0.013,respectively). There was no significant correlation of gene expression with gender,age,smoking status,performance status, clinical stages and histological types of patients (P>0.05).Significant difference was found in response rate to chemotherapy(P<0.05,P<0.01,P<0.05),median survival time(P<0.05,P<0.01,P<0.05) and 1-year survival rate (P<0.01,<0.05,P<0.05) between patients with low RRM1 and ERCC1 expression levels in tumor tissues or low RRM1 expression levels in peripheral blood and those with high RRM1 and ERCC1 expression levels.The patients with low ERCC1 expression levels in tumor tissues gained higher 2-year survival rate(P<0.05).There was no correlation of the expression of ERCC1 in peripheral blood with the response to chemotherapy and prognosis(P>0.05). 
Conclusion: The expression of RRMI and ERCC1 genes in tumor tissues and RRM1 in peripheral blood lymphocytes is closely correlated with the response to chemotherapy and prognosis of patients with advanced NSCLC treated with gemcitabine plus carboplatin.

 

论文联盟医学期刊论文发表网是专业的医学sci论文发表网,如果您需要发表医学sci论文需要翻译润色,请联系我们:

腾讯营销QQ:800006877

也可联络如下客服个人QQ:

卢老师:
在线QQ:100759325  
电话/微信:159 555 38603 
咨询/投稿E-mail:lulaoshi@lwlm.com

林老师:
在线QQ:912673502 
电话/微信:189 8197 5885
咨询/投稿E-mail:linlaoshi@lwlm.com

张老师:
在线QQ:759325 
电话/微信: 133 4891 3310 
咨询/投稿E-mail:lwlm@lwlm.com 

收藏 推荐 打印 | 录入:论文联盟

本文评论   查看全部评论 (0)
表情: 评论表情符号选择 姓名: 字数
点评:
       
评论声明
  • 尊重网上道德,遵守中华人民共和国的各项有关法律法规
  • 承担一切因您的行为而直接或间接导致的民事或刑事法律责任
  • 本站管理人员有权保留或删除其管辖留言中的任意内容
  • 本站有权在网站内转载或引用您的评论
  • 参与本评论即表明您已经阅读并接受上述条款
站内搜索
网站客服